Jump to start of content

Complete requirements by 12/31/19 to avoid a change in certification status Expand/Collapse the ABIM alert.

Sign in to your Physician Portal to view any remaining requirements for the year. Not completing these requirements by 12/31/19 could result in a change to your certification status.

Breadcrumb trail:

Cardiovascular Board Clinical Cardiac Electrophysiology Exam Committee

Expand All | Collapse All

Bradley P. Knight, MD, Chair

Bradley P. Knight, MD, ChairDr. Knight is board certified in Internal Medicine, Cardiovascular Disease and Clinical Cardiac Electrophysiology. At Northwestern Memorial Hospital, Dr. Knight is an attending cardiac electrophysiologist, Director of Cardiac Electrophysiology, Director of the Cardiac Electrophysiology Laboratory and Director of Electrocardiography. He is also the Medical Director for the Center of Heart Rhythm Disorders at the Bluhm Cardiovascular Institute. He is a Professor of Medicine at Northwestern University Feinberg School of Medicine and a member of the Northwestern Medical Faculty Foundation.

Dr. Knight joined the University of Michigan faculty in 1997 and then moved to the University of Chicago in 2002 where he was the Director of Cardiac Electrophysiology for seven years.

Considered an expert in the management of patients with heart rhythm disorders, Dr. Knight's clinical interests remain broad and include management of all types of heart rhythm disorders, and implantation of cardiac rhythm management devices such as pacemakers and defibrillators. His research interests include atrial fibrillation; catheter ablation for complex arrhythmias, including atrial fibrillation; intracardiac imaging techniques; diagnostic maneuvers used in the electrophysiology laboratory; the use of defibrillators in patients with syncope and a cardiomyopathy; sudden cardiac arrest; and pacing to improve heart failure. He has been an investigator for several multicenter clinical trials, and is on the editorial board of several major medical journals. He has published over 200 peer-reviewed manuscripts, reviews, case reports and editorials. He is currently the Editor of EP Lab Digest.

Dr. Knight is Chair of the American Board of Internal Medicine Cardiovascular Board Clinical Cardiac Electrophysiology Exam Committee. He is also an active member of the Heart Rhythm Society, American College of Cardiology and the American Heart Association.

Dr. Knight earned his bachelor's degree at the University of North Carolina, Chapel Hill in the School of Public Health, and his medical degree at The Ohio State University. He completed his training in medicine, cardiology and cardiac electrophysiology at the University of Michigan.

As of February 2019, Dr. Knight reported the following external relationships:

Funding for preclinical trial research staff, paid to Northwestern University, from the following companies:

  • Abbott, for a study comparing the Amulet versus Watchman devices.
  • Medtronic, for a study of a cyroballon post-approval study and for an acute extravascular defibrillation, pacing, and electrogram trial.

Attendance at investigators’ meetings, with compensation for travel expenses and honoraria from the following company:

  • Medtronic, for a study of a cyroballon post-approval study and for an acute extravascular defibrillation, pacing, and electrogram trial.

Service on data and safety monitoring boards for the following company, with honoraria:

  • Sanofi, for serving as a dupilumab data safety monitoring committee member via ACI Clinical.

Service on a research-related expert panel or advisory board for the following company, with compensation for travel expenses and honoraria:

  • Boston Scientific, for serving as a global business advisory board member.

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following company, with compensation as listed:

  • Agama Medical, for development of a catheter ablation tool for atrial fibrillation ablation.

Industry-supported continuing medical education supporting electrophysiology fellows educational programs by the following, with compensation for travel expenses and honoraria:

  • Abbott
  • Biotronik
  • Boston Scientific
  • Medtronic

Teaching in satellite symposia funded by the following companies, with honoraria:

  • Boston Scientific, for a WebEd Symposium on an SQ Implantable Cardioverter Defibrillator.

Providing FDA-required training in the use of devices with compensation as listed:

  • Medtronic, participating in physician proctoring outside the United States and as required by the FDA in the United States on the use of the cryoballoon for the treatment of atrial fibrillation, receiving reimbursement for travel expenses and honoraria.

Dr. Knight serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American Heart Association, Get With The Guidelines® Program Committee Member, without compensation.
  • Heart Rhythm Society, Member of Finance Committee, without compensation.

Emile Daoud, MD

Emile Daoud, MDDr. Daoud is Professor, Internal Medicine at the Wexner Medical Center at The Ohio State University in Columbus, Ohio. He serves as the Chief of Cardiac Electrophysiology since 2007. He is board certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology.

From 1998 to 2007, Dr. Daoud was Director of Electrophysiology Research with the Midwest Research Foundation and worked as a Clinical Electrophysiologist with MidOhio Cardiology at Riverside Methodist Hospital, before joining The Ohio State University in 2007. Prior to that, following fellowship training, he was Assistant Professor at the University of Michigan for three years before relocating to Columbus, Ohio.

Dr. Daoud has published more than 150 manuscripts, and has a particular interest in ablation of atrial and ventricular arrhythmias and device therapy, including biventricular pacing, subcutaneous defibrillators, and leadless pacing systems. He is currently a Fellow of the American College of Cardiology and a Fellow of the Heart Rhythm Society, as well as a member of the American Heart Association. He has been listed as America's Best Doctors in the U.S. News and World Report, a Top 10 faculty educator at The Ohio State University Medical Center, and has served on numerous national steering committees and advisory boards, including serving as a member of the American Board of Internal Medicine Cardiovascular Board Clinical Cardiac Electrophysiology Exam Committee.

Dr. Daoud received his undergraduate degree from University of Notre Dame, and his medical degree from the University of Cincinnati. He then completed internal medicine training at The Johns Hopkins Hospital (1988-1991) in Baltimore, Maryland, and cardiology fellowship and subspecialty training in electrophysiology at the University of Michigan (1991-1995) in Ann Arbor, Michigan.

As of February 2019, Dr. Daoud reported the following external relationships:

Funding for clinical trial expenses and staff, paid to The Ohio State University, from the following companies:

  • Biosense Webster, for a trial on novel radiofrequency ablation catheter designed for treating paroxysmal atrial fibrillation and for a trial to assess the safety and efficacy of a left atrial appendage occlusion system to reduce the risk of embolic stroke in atrial fibrillation patients.
  • Biotronik, for a right atrium and right venticular pacing lead trial.
  • Boston Scientific, for a trial on quadripolar cardiac resynchronisation therapy/ left ventricular lead.
  • DECAAR, for a trial on ablation of persistent atrial fibrillation using an MRI fibrosis map.
  • EBR Systems, for a trial of a plunge electrode for left ventricular pacing using ultrasound energy.
  • Medtronic, for a trial on cardiac resynchronisation therapy, for a trial to assess the safety and effectiveness of a novel cryoballoon ablation technology designed to achieve single-delivery pulmonary vein isolation, and for a trial of an implantable cardioverter defibrillator for ejection fraction.
  • S4Medical, for an esophageal deviation study.

Attendance at investigators’ meetings, with compensation for travel expenses and honoraria from the following companies:

  • Biosense Webster, for a trial on an irrigated circular ablation catheter for atrial fibrillation.
  • S4Medical, for an esophageal deviation study.
  • Service on a research-related expert panel or advisory board for the following companies, with compensation for travel expenses and honoraria:

    • Biosense Webster, advising on design of an investigational device exemption and subsequent clinical trial with new mapping tool for atrial fibrillation rotors.
    • Biotronik, serving on an advisory board for leadless pacing and an expert panel regarding His bundle pacing technology.
    • St. Jude, advising on design of a cardiac resynchronization therapy.

    Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, with compensation for travel expenses and honoraria:

    • Biotronik, consulting on leadless pacing and His bundle pacing technology.

    Dr. Daoud serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

    • Heart Rhythm Society, Chair for Cardiac Implantable Electronic Devices Educational Committee, without compensation.
    • S4Medical, Board Member, Inventor of its esophageal protection device for atrial fibrillation ablation procedures, receiving consulting fees and stock equity.

    Nathan A. Mark Estes III, MD

    Nathan A. Mark Estes III, MDDr. Estes is Professor of Medicine at Tufts University School of Medicine and Director of the Cardiac Arrhythmia Service at Tufts Medical Center, Boston, Massachusetts. He is board certified in Internal Medicine, Cardiovascular Disease and Clinical Cardiac Electrophysiology.

    Dr. Estes is a member of the American Board of Internal Medicine Cardiovascular Board Clinical Cardiac Electrophysiology Exam Committee and has served on the Examination Writing Committee for the International Board of Heart Rhythm Examiners. He has served as the President of the Boston Board and Northeast Affiliate of the American Heart Association (AHA), Chairman of the AHA Council on Clinical Cardiology, and President of the Heart Rhythm Society. Dr. Estes has co-Chaired the Performance Measure Writing Committee of the American College of Cardiology (ACC) and AHA Atrial Fibrillation Performance Measures. He has served on the Performance Measures Committee of the Heart Rhythm Society and on the Quality Metrics Task Force of the ACC.

    Dr. Estes is the Editor-in-Chief of UpToDate in Cardiology. He has received multiple awards and honors, including being elected to Alpha Omega Alpha at the University of Cincinnati, the University of Pennsylvania Award of Merit, Moses Brown School Distinguished Achievement Award, the AHA Paul Dudley White Award and the Distinguished Leadership Award of the AHA. Dr. Estes also has been recognized with the President's Award of the Heart Rhythm Society (2013), the Distinguished Achievement Award of the European Cardiac Arrhythmia Society (2014) and the AHA Distinguished Achievement Award (2014).

    Dr. Estes received his undergraduate degree from the University of Pennsylvania and his medical degree from the University of Cincinnati. He completed medical training at the Deaconess Hospital, cardiology training at Tufts Medical Center, and clinical cardiac electrophysiology training at Massachusetts General Hospital.

    As of April 2019, Dr. Estes reported the following external relationships:

    Service on data and safety monitoring boards for the following company, receiving reimbursement for travel and honoraria:

    • Milestone Pharmaceuticals, Independent Physician Quality Panel Member.

    Work funded by educational grants from industry, paid to Dr. Estes, from the following companies:

    • Boston Scientific, receiving salary support for Director of educational course for fellows.
    • St. Jude, receiving salary support for Director of educational course for fellows.

    Work as an author or editor for following company, with compensation as listed:

    • UpToDate, receiving compensation as editor-in-chief of cardiovascular section.

    Dr. Estes serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

    • American Heart Association, Chair of Scientific Publications Committee, without compensation.
    • Heart Rhythm Society, Nominations Committee, without compensation.

    Paul A. Friedman, MD

    Paul A. Friedman, MDDr. Friedman is a Professor of Medicine and Vice Chair of the Department of Cardiovascular Medicine and Vice Chair for Academic Affairs and Faculty Development at Mayo Clinic, Rochester, Minnesota. He also serves as Medical Director for Remote Monitoring. He is board certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology.

    Previously, Dr. Friedman served as Director of the Cardiac Implantable Device Lab, Mayo Clinic. He is a trained electrical engineer, with deep experience in innovation (with more than 40 patents issued, he was named Minnesota Top Inventor), and scientific research (more than 250 scientific original publications). He is a member of the American Board of Internal Medicine Cardiovascular Board Clinical Cardiac Electrophysiology Exam Committee and a committed educator, serving as a director for five national and international meetings, editor of seven textbooks and author of more than 60 book chapters. He is a frequent visiting professor and lecturer at educational meetings.

    Dr. Friedman earned a bachelor's degree in liberal arts and bachelor's degree in electrical engineering from the University of Texas at Austin. He received his medical degree from Stanford University, and trained in internal medicine at the University of Washington, Seattle and Stanford University. He trained in cardiovascular medicine and cardiac electrophysiology at Mayo Clinic.

    As of June 2019, Dr. Friedman reported the following external relationships:

    Attendance at investigators' meetings, with compensation for travel expenses and honoraria from the following companies:

    • Medtronic, for a clinical trial of an implantable cardioverter-defibrillator to detect atrial fibrillation.
    • St. Jude, for a steering committee for a clinical trial of a leadless pacemaker, paid to the Mayo Clinic.

    Service on data and safety monitoring boards for the following company, with honoraria:

    • Boston Scientific, for a longitudinal study on device performance and for an Advanced Life Support study.

    Service on a research-related expert panel or advisory board for the following companies, with compensation for travel expenses and/or honoraria:

    • Boston Scientific, for a cardiac rhythm management advisory board, receiving reimbursement for travel expenses and honoraria.
    • Medtronic, for an advisory board on the development of a novel defibrillator, receiving reimbursement for travel expenses.

    Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, with equity provided to the Mayo Clinic.

    • CardioThrive, for testing a novel form of a defibrillator.
    • Leadexx, for consulting on a clinical trial of a novel extraction tool.

    Dr. Friedman serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

    • Heart Rhythm Society, Board of Trustees, receiving reimbursement for travel expenses and honoraria.

    Dr. Friedman also reported that he will soon receive royalities for intellectual property that the Mayo Clinic has licenses to Champion.

    David E. Haines, MD

    David E. Haines, MDDr. Haines is Professor of Cardiovascular Medicine at Oakland University-William Beaumont School of Medicine and the Director of the Heart Rhythm Center at Beaumont Health in Royal Oak, Michigan. He is also a former Director of the Clinical Cardiac Electrophysiology (CCEP) Fellowship program. He is board certified in Clinical Cardiac Electrophysiology, Cardiovascular Disease and Internal Medicine. He is a fellow of both the Heart Rhythm Society and the American College of Cardiology.

    Previously, Dr. Haines was Professor of Medicine at the University of Virginia. At that institution, he was Director of the CCEP Fellowship program from 1989 to 2003 and Director of the Cardiovascular Fellowship Training Program from 1988 to 2002.

    Dr. Haines is currently the President of the Intersocietal Accreditation Commission for Cardiac Electrophysiology and a member of the Cardiovascular Board Clinical Cardiac Electrophysiology Exam Committee of the American Board of Internal Medicine. He has served the Heart Rhythm Society (HRS) as Vice Chair of the Scientific and Clinical Documents Committee, Chair of the Fellowship and Training Committee, and on numerous other committees and task forces. Between 1999 and 2013, Dr. Haines was co-Chair of the HRS Board Review Course. Dr. Haines has also volunteered his services on several committees for the American College of Cardiology (ACC) and as the ACC Governor of Virginia.

    Dr. Haines received his bachelor's degree from Williams College, Williamstown, Massachusetts, and his medical degree from the University of Rochester School of Medicine and Dentistry, Rochester, New York. He completed his internal medicine training at the University of Vermont, Burlington, Vermont, and his cardiology and clinical cardiac electrophysiology training at the University of Virginia, Charlottesville, Virginia.

    As of April 2019, Dr. Haines reported the following external relationships:

    Preclinical research, with funding paid to Beaumont Health, from the following companies:

    • Affera, with funding for clinical trial expenses and research staff.LuxCath, with funding for clinical trial expenses and research staff.
    • Medtronic, for a study of new ablation catheters, with funding for clinical trial expenses, salary support, and research staff.

    Funding for clinical trial expenses, salary support and staff, paid to Beaumont Health, from the following companies:

    • Abbott, for a study of left atrial appendage occlusion, receiving funding for clinical trial expenses and staff.
    • Biosense Webster, for a study of left atrial appendage occlusion, receiving funding for clinical trial expenses and staff.
    • Bristol-Myers Squibb, for a study of treatment with apixaban, compared with aspirin, to reduce the risk of ischemic stroke and systemic embolism in patients with device-detected sub-clinical atrial fibrillation and additional risk factors for stroke, receiving funding for clinical trial expenses and staff.
    • Boston Scientific, for a catheter ablation study, a study for treating heart failure, and a study of a subcutaneous implantable defibrillator, receiving funding for clinical trial expenses, salary support and staff.

    Service on a research-related expert panel or advisory board for the following companies, with compensation for travel expenses and honoraria:

    • Boston Scientific, for service on a steering committee.
    • Medtronic, for service on a steering committee.

    Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, with compensation for travel expenses and honoraria:

    • Affera
    • Biosense Webster
    • Dragon Consulting
    • LuxCath
    • 3D ICE
    • VerAFeye
    • Integer
    • Philips
    • Zoll

    Industry-supported continuing medical education supported by the following, with compensation for travel expenses and honoraria:

    • Biosense Webster

    Western Atrial Fibrillation Symposium - providing FDA-required training in the use of devices with honoraria from the following company:

    • Boston Scientific, for a device for atrial fibrillation.

    Dr. Haines serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

    • Heart Rhythm Society, Chair of Corporate Relations Committee, Board of Trustees, without compensation.
    • Intersocietal Accreditation Commission, Board Member, receiving reimbursement for travel expenses.

    Jodie L. Hurwitz, MD

    Dr. Hurwitz is currently a partner at North Texas Heart Center in Dallas. She has been with this group for 25 years. She is also Director of Electrophysiology at Medical City Dallas Hospital, where she serves as Chair of Cardiology. Additionally, she is Head of Electrophysiology/CIED at North Texas Heart Center. She is board certified in Internal Medicine, Cardiology and Clinical Cardiac Electrophysiology.

    Previously, Dr. Hurwitz had been at the Hospital of the University of Pennsylvania where she was Head of Pacing. Before that, she was on staff at Duke University Medical Center after she finished her fellowship there.

    Dr. Hurwitz is currently a member of the American Board of Internal Medicine Cardiovascular Board Clinical Cardiac Electrophysiology Exam Committee. She is also board member of the Heart Rhythm Society, where she previously served as Chair of the Membership Committee for two years. Dr. Hurwitz is on the editorial board of the Journal of Clinical Electrophysiology and Circulation-Electrophysiology. She was previously a member of the American College of Cardiology Foundation EP/EKG Committee, where she also served as Chair for two years.

    Dr. Hurwitz received her bachelor’s degree in chemistry from Mount Holyoke College and her medical degree from Albert Einstein College of Medicine. She completed her internship and residency at UT Southwestern Health Care System and her cardiology/electrophysiology fellowship at Duke University Medical Center.

    As of May 2019, Dr. Hurwitz reported the following external relationships:

    Post-marketing clinical research, with funding for research staff and expenses provided to North Texas Heart Center, from the following companies:

    • Medtronic, providing funding for a study to randomize use of a pouch in reducing the risk of cardiac implantable electronic device infection.
    • Bristol-Myers Squibb, providing funding for a study of apixaban for the reduction of thrombo-embolism in patients with device-detected subclinial atrial fibrillation.

    Teaching in satellite symposia funded by the following company, with compensation for travel expenses and honoraria:

    • Medtronic, Chair of the Women in Electrophysiology Conference.

    Dr. Hurwitz serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

    • American College of Cardiology, Ex-Chair of Electrophysiology Committee, without compensation.
    • Heart Rhythym Society, Board Member, without compensation.

    Dr. Hurwitz is also a Partner at The Heart Hospital Baylor Plano.

    Kalyanam Shivkumar, MD, PhD

    Kalyanam Shivkumar, MD, PhDDr. Shivkumar is a physician scientist who serves as the Director of The University of California, Los Angeles (UCLA) Cardiac Arrhythmia Center and Clinical Cardiac Electrophysiology Program since the Arrhythmia Center's establishment in 2002. He is currently Professor of Medicine and has joint appointments in Radiology and Bioengineering.His field of specialization is interventional cardiac electrophysiology and he leads a group at UCLA that is involved in clinical care, teaching, research and biomedical innovation. The team provides state of the art clinical care, has developed several innovative techniques (e.g., epicardial mapping) for the non-pharmacological management of cardiac arrhythmias and other cardiac interventions. The team has a major focus on mechanistic research. Dr. Shivkumar's research work relates to mechanisms of cardiac arrhythmias in humans especially the role of the autonomic nervous system and neurovisceral sciences in general. The UCLA Neurocardiology Research Center of Excellence was established as the specialized research arm of the Arrhythmia Center in 2014.

    Dr. Shivkumar has received several teaching awards and serves as a member of the American Board of Internal Medicine Cardiovascular Board Clinical Cardiac Electrophysiology Exam Committee. He has been elected to the membership of the American Society of Clinical Investigation (ASCI) and serves as the institutional representative of UCLA for the ASCI. He has also been elected as an honorary fellowship of the Royal College of Physicians.

    Dr. Shivkumar received his medical degree from the University of Madras, India, in 1991 and his doctoral degree from UCLA in 2000. He completed his cardiology fellowship training at UCLA, and upon completion of his training joined the faculty at University of Iowa, where he also served as the Associate Director of Cardiac Electrophysiology.

    As of April 2019, Dr. Shivkumar reported the following external relationships:

    Dr. Shivkumar holds a healthcare-related patent for FDA-approved products for the prevention of air embolism and stroke, with income from EP Dynamics, Inc. He is also the founder of EP Dynamics, Inc.

    Dr. Shivkumar serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

    • Heart Rhythm Society, Publication Sub-Committee Member, Section Editor and Ambassador to India, without compensation.

    Dr. Shivkumar also reported he serves as the Data and Safety Monitoring Board Chair for VytronUS. He also receives grant funding from the National Institutes of Health for salary support and other project expenses.

    Usha B. Tedrow, MD, PhD

    Usha B. Tedrow, MD, PhDDr. Tedrow is an invasive clinical cardiac electrophysiologist with clinical expertise in complex catheter ablation, particularly ablation of ventricular tachycardia (VT). She is an an expert in the use of novel technologies to address hard-to-reach intramural substrate for ventricular arrhythmias, currently a major source of VT ablation failure. In addition, she is the Director of the Clinical Cardiac Electrophysiology (CCEP) program at Brigham and Women's Hospital, and lectures in the core curriculum for the CCEP fellows and develops the educational curriculum. On a national level, she is the Heart Rhythm Society Representative on the recent COCATS Task Force addressing updated guidelines for training in Cardiac Electrophysiology; she is also the Chair of the Heart Rhythm Society Program Directors' Subcommittee, where among other activities, she has been involved in developing an in-training examination for fellows in CCEP. She is an Associate Editor for the Journal of the American College of Cardiology's Electrophysiology Journal and has been an editorial board member for the journal Circulation: Arrhythmia and Electrophysiology.

    Clinically, Dr. Tedrow performs invasive catheter ablation of ventricular and supraventricular tachycardia, as well as implantation of cardiac devices (pacemakers, defibrillators, resynchronization devices). Additionally, she performs percutaneous epicardial ablation, a specialized quaternary referral procedure, as well as needle catheter ablation under an institutional FDA IDE. In addition, it is worth mentioning that nationally less than10% of electrophysiologists are female and of these only a fraction performs complex ablation.

    Dr. Tedrow is able to meld high-level clinical expertise in highly specialized invasive cardiac electrophysiology with the administrative challenges of running an academic electrophysiology program, while cultivating exciting clinical research.

    As of August 2018, Dr. Tedrow reported the following external relationships:

    Dr. Tedrow serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

    • Heart Rhythm Society, Chair of Program Directors' Subcommittee, without compensation.